UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Acute liver failure in Sweden: etiology and outcome

Journal of internal medicine, 2007-09, Vol.262 (3), p.393-401

2007

Link zum Volltext

Verfügbarkeit prüfen

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

Alimentary pharmacology & therapeutics, 2012-02, Vol.35 (4), p.451-457

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

Journal of hepatology, 2002, Vol.36 (3), p.321-327

2002

Link zum Volltext

Verfügbarkeit prüfen

Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives

Gastroenterology (New York, N.Y. 1943), 2003, Vol.125 (6), p.1733-1741

2003

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: A 5-Year Multicenter, Randomized, Controlled Study

Gastroenterology (New York, N.Y. 1943), 2005-11, Vol.129 (5), p.1464-1472

2005

Link zum Volltext

Verfügbarkeit prüfen

Increased Risk of Primary Sclerosing Cholangitis and Ulcerative Colitis in First-Degree Relatives of Patients With Primary Sclerosing Cholangitis

Clinical gastroenterology and hepatology, 2008, Vol.6 (8), p.939-943

2008

Link zum Volltext

Verfügbarkeit prüfen

Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)

Journal of hepatology, 2002, Vol.36 (5), p.586-589

2002

Link zum Volltext

Verfügbarkeit prüfen

Intensive intravenous treatment of ulcerative colitis

Gastroenterology (New York, N.Y. 1943), 1985-11, Vol.89 (5), p.1005-1013

1985

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: A nationwide study

Scandinavian journal of gastroenterology, 2008, Vol.43 (10), p.1232-1240

2008

Link zum Volltext

Verfügbarkeit prüfen

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

Gut, 1996-04, Vol.38 (4), p.610-615

1996

Link zum Volltext

Verfügbarkeit prüfen

Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients

Journal of hepatology, 2009-02, Vol.50 (2), p.388-393

2009

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response

Scandinavian journal of gastroenterology, 2010-04, Vol.45 (4), p.457-467

2010

Link zum Volltext

Verfügbarkeit prüfen

Platelet density and size in inflammatory bowel disease

Thrombosis and haemostasis, 1996-04, Vol.75 (4), p.560

1996

Link zum Volltext

Verfügbarkeit prüfen

883 EPIDEMIOLOGY AND THE INITIAL PRESENTATION OF AUTOIMMUNE HEPATITIS TYPE 1 IN SWEDEN, A NATIONWIDE STUDY

Journal of hepatology, 2008, Vol.48, p.S331-S332

2008

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune hepatitis among fertile women: Strategies during pregnancy and breastfeeding?

Scandinavian journal of gastroenterology, 2007-01, Vol.42 (8), p.986-991

2007

Link zum Volltext

Verfügbarkeit prüfen

Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population

Scandinavian journal of gastroenterology, 2011-09, Vol.46 (9), p.1118-1126

2011

Link zum Volltext

Verfügbarkeit prüfen

Validation of the Inflammatory Bowel Disease Questionnaire in Swedish Patients with Ulcerative Colitis

Scandinavian journal of gastroenterology, 2001, Vol.36 (1), p.77-85

2001

Link zum Volltext

Verfügbarkeit prüfen

Azodisal sodium in the treatment of ulcerative colitis: a study of tolerance and relapse-prevention properties

Gastroenterology (New York, N.Y. 1943), 1986-04, Vol.90 (4), p.1024-1030

1986

Link zum Volltext

Verfügbarkeit prüfen

Primary amyloidosis with spontaneous splenic rupture, cholestasis, and liver failure treated with emergency liver transplantation

The American journal of gastroenterology, 1998-11, Vol.93 (11), p.2254-2256

1998

Link zum Volltext

Verfügbarkeit prüfen

Hermansky-Pudlak Syndrome with Colitis and Pulmonary Fibrosis

Scandinavian journal of gastroenterology, 1999, Vol.34 (10), p.1055-1056

1999

Link zum Volltext

Verfügbarkeit prüfen

HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis

Tissue antigens, 2002-05, Vol.59 (5), p.381-387

2002

Link zum Volltext

Verfügbarkeit prüfen

Increased Mortality Risk in Patients With Phenotypic Hereditary Hemochromatosis But Not in Their First-Degree Relatives

Gastroenterology (New York, N.Y. 1943), 2009, Vol.137 (4), p.1301-1309

2009

Link zum Volltext

Verfügbarkeit prüfen

Optimum dose of olsalazine for maintaining remission in ulcerative colitis

Gut, 1994-09, Vol.35 (9), p.1282-1286

1994

Link zum Volltext

Verfügbarkeit prüfen

The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis

European journal of gastroenterology & hepatology, 2003-09, Vol.15 (9), p.1011-1020

2003

Link zum Volltext

Verfügbarkeit prüfen

Cancer risk in primary biliary cirrhosis: A population‐based study from Sweden

Hepatology (Baltimore, Md.), 1994-07, Vol.20 (1), p.101-104

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(41)
Tagungsberichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(33)
Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Gastroenterology & Hepatology
(29)
Adult
(27)
Female
(27)
Male
(26)
Middle Aged
(26)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Medicin Och Hälsovetenskap
(22)
Aged
(20)
Clinical Medicine
(17)
Klinisk Medicin
(17)
Medical And Health Sciences
(17)
Medicin
(17)
Medicine
(17)
Gastroenterology And Hepatology
(16)
Gastroenterologi
(15)
Gastroenterology. Liver. Pancreas. Abdomen
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute liver failure in Sweden: etiology and outcome

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives

High-Dose Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: A 5-Year Multicenter, Randomized, Controlled Study

Increased Risk of Primary Sclerosing Cholangitis and Ulcerative Colitis in First-Degree Relatives of Patients With Primary Sclerosing Cholangitis

Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)

Intensive intravenous treatment of ulcerative colitis

Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: A nationwide study

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients

Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response

Platelet density and size in inflammatory bowel disease

883 EPIDEMIOLOGY AND THE INITIAL PRESENTATION OF AUTOIMMUNE HEPATITIS TYPE 1 IN SWEDEN, A NATIONWIDE STUDY

Autoimmune hepatitis among fertile women: Strategies during pregnancy and breastfeeding?

Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population

Validation of the Inflammatory Bowel Disease Questionnaire in Swedish Patients with Ulcerative Colitis

Azodisal sodium in the treatment of ulcerative colitis: a study of tolerance and relapse-prevention properties

Primary amyloidosis with spontaneous splenic rupture, cholestasis, and liver failure treated with emergency liver transplantation

Hermansky-Pudlak Syndrome with Colitis and Pulmonary Fibrosis

HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis

Increased Mortality Risk in Patients With Phenotypic Hereditary Hemochromatosis But Not in Their First-Degree Relatives

Optimum dose of olsalazine for maintaining remission in ulcerative colitis

The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis

Cancer risk in primary biliary cirrhosis: A population‐based study from Sweden

Suchergebnisse filtern